Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Moderna Inc.

Analysts are intrested in these 5 stocks: ( ($PYPL) ), ( ($SOUN) ), ( ($MRNA) ), ( ($DVN) ) and ( ($BMY) ). Here is a breakdown of their recent


PayPal, SoundHound, Moderna, Devon, Bristol-Myers: Trending by Analysts

The SPDR S&P 500 ETF Trust ($SPY) was up 0.07% on Thursday, logging its third consecutive day of gains. Its performance was impacted by mixed labor...

SPY ETF Daily Update, 12/4/2025

The SPDR S&P 500 ETF Trust ($SPY) gained 0.35% on Wednesday, with support from the strong performance of certain stocks such as Tesla ($TSLA), Unit...

SPY ETF Daily Update, 12/3/2025

The Vanguard S&P 500 ETF ($VOO) gained 0.17% on Tuesday as bond yields and Bitcoin stabilized after sharp moves in the previous session. Also, the ...

Vanguard S&P 500 ETF (VOO) Daily Update, 12/3/2025

In a report released today, Courtney Breen from Bernstein maintained a Hold rating on Moderna, with a price target of $25.00. Breen covers the Heal...

Moderna (MRNA) Gets a Hold from Bernstein

Shares of major COVID-19 vaccine makers, Moderna ($MRNA), BioNTech ($BNTX), and Novavax ($NVAX) fell 6%, 5%, and 4%, respectively, on Monday. The d...

MRNA, NVAX, BNTX: Here’s What Triggered a Sell-off in Major Vaccine Stocks Today

Everything to Know about Macro and Markets U.S. stocks ended the week higher as markets cheered signs of slower inflation and rising odds of a Fede...

The Week That Was, The Week Ahead: Macro & Markets, November 30

The SPDR S&P 500 ETF Trust ($SPY) gained 0.55% on Friday, primarily driven by a rally in chip stocks, optimism about potential future Federal Reser...

SPY ETF Daily Update, 11/28/2025

The Vanguard S&P 500 ETF ($VOO) rose 0.93% on Wednesday, supported by renewed optimism over possible Federal Reserve rate cuts and strength in tech...

Vanguard S&P 500 ETF (VOO) Daily Update, 11/27/2025

Analysts fell to the sidelines weighing in on Moderna (MRNA – Research Report) and Fisher & Paykel Healthcare Corporation Limited (FSPKF – Research...

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)

The Vanguard S&P 500 ETF ($VOO) rose 0.93% on Tuesday, supported by growing expectations of Federal Reserve rate cuts and upbeat earnings from reta...

Vanguard S&P 500 ETF (VOO) Daily Update, 11/26/2025

The SPDR S&P 500 ETF Trust ($SPY) rose 0.99% on Friday, as the New York Fed President John Williams’ speech revived hopes of an interest rate cut i...

SPY ETF Daily Update, 11/24/2025

In a report released today, Cory Kasimov from Evercore ISI maintained a Hold rating on Moderna, with a price target of $28.00. According to TipRank...

Evercore ISI Remains a Hold on Moderna (MRNA)

RBC Capital analyst Luca Issi reiterated a Hold rating on Moderna yesterday and set a price target of $25.00. The company’s shares closed yesterday...

RBC Capital Reaffirms Their Hold Rating on Moderna (MRNA)

The Vanguard S&P 500 ETF ($VOO) gained 0.36% on Wednesday, snapping a four-day slide. The ETF is also up 1.10% in pre-market trading today after Nv...

Vanguard S&P 500 ETF (VOO) Daily Update, 11/20/2025

Moderna ($MRNA) steps into Thursday’s analyst day with more pressure than momentum. The stock is down more than 40% this year and over 85% in three...

Moderna Stock (MRNA) Faces a Cash Crunch Test as Analyst Day Arrives

The SPDR S&P 500 ETF Trust ($SPY) closed 0.02% lower on Friday. Volatility in the technology sector and concerns about a potential delay in Federal...

SPY ETF Daily Update, 11/14/2025

Moderna ( ($MRNA) ) has provided an update. On November 12, 2025, Moderna, Inc. held a Special Meeting of Shareholders where two proposals were app...

Current Yield	N/A	Payout Ratio	0.00%
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	MRNA	$29.46	-0.57%	12.31M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	MRNA	$29.46	-0.6%	12.31M
3
4
5
6

MRNA

MRNA

Dividend Overview

Get Moderna Inc. Data in Excel

Get Moderna Inc. Data in Excel